| __timestamp | Amneal Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 34916000 |
| Thursday, January 1, 2015 | 109679000 | 36949000 |
| Friday, January 1, 2016 | 118757000 | 45240000 |
| Sunday, January 1, 2017 | 109046000 | 62416000 |
| Monday, January 1, 2018 | 230435000 | 81289000 |
| Tuesday, January 1, 2019 | 289598000 | 100359000 |
| Wednesday, January 1, 2020 | 326727000 | 105326000 |
| Friday, January 1, 2021 | 365504000 | 122356000 |
| Saturday, January 1, 2022 | 399700000 | 152848000 |
| Sunday, January 1, 2023 | 429675000 | 184259000 |
Cracking the code
In the competitive landscape of pharmaceuticals, understanding the financial dynamics of companies is crucial. Over the past decade, Corcept Therapeutics and Amneal Pharmaceuticals have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Amneal Pharmaceuticals' SG&A expenses surged by over 400%, peaking at approximately $430 million in 2023. In contrast, Corcept Therapeutics exhibited a more moderate increase, with expenses rising by about 430% to reach nearly $184 million in the same year.
This divergence highlights Amneal's aggressive expansion strategy, possibly reflecting higher operational costs or increased marketing efforts. Meanwhile, Corcept's steady growth suggests a more controlled approach to scaling operations. These insights provide a window into the strategic priorities of each company, offering valuable lessons for stakeholders and investors alike.
SG&A Efficiency Analysis: Comparing Novartis AG and Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
argenx SE or Corcept Therapeutics Incorporated: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Incyte Corporation and Corcept Therapeutics Incorporated
Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Catalent, Inc. or Amneal Pharmaceuticals, Inc.
Blueprint Medicines Corporation or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Alkermes plc
Corcept Therapeutics Incorporated and Perrigo Company plc: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
SG&A Efficiency Analysis: Comparing Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?